德源药业
(832735)
| 流通市值：38.09亿 | | | 总市值：43.06亿 |
| 流通股本：6917.15万 | | | 总股本：7821.07万 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 255,089,983.62 | 868,464,593.56 | 652,939,581.37 | 432,481,805.86 |
| 营业收入 | 255,089,983.62 | 868,464,593.56 | 652,939,581.37 | 432,481,805.86 |
| 二、营业总成本 | 194,770,581.21 | 682,130,948.16 | 524,560,221.68 | 343,009,605.23 |
| 营业成本 | 35,733,172.62 | 134,078,358.92 | 102,069,349.7 | 66,662,407.56 |
| 税金及附加 | 3,908,689.55 | 11,592,085.61 | 9,378,212.45 | 6,171,507.94 |
| 销售费用 | 111,326,869.14 | 370,764,293.46 | 281,352,036.55 | 184,891,496.05 |
| 管理费用 | 14,118,372.14 | 53,950,362.76 | 37,474,511.51 | 23,268,416.72 |
| 研发费用 | 29,736,386.85 | 116,964,755.38 | 97,810,466.84 | 64,855,171.5 |
| 财务费用 | -52,909.09 | -5,218,907.97 | -3,524,355.37 | -2,839,394.54 |
| 其中:利息费用 | 198,911.1 | 799,771.22 | 572,516.42 | 376,823.56 |
| 其中:利息收入 | 270,722.81 | 6,075,459.31 | 4,142,878.61 | 3,245,691.73 |
| 加:公允价值变动收益 | 1,181,411.43 | 66,684.93 | 396,465.74 | 317,013.32 |
| 加:投资收益 | 1,214,748.75 | 4,739,100.37 | 2,811,381.76 | 630,228.06 |
| 信用减值损失(新) | -731,392.44 | -805,383.05 | -1,452,002.44 | -1,714,987.28 |
| 其他收益 | 1,297,979.33 | 8,612,443.19 | 6,566,654.08 | 6,132,258.17 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 63,282,149.48 | 198,946,490.84 | 136,701,858.83 | 94,836,712.9 |
| 加:营业外收入 | 156,290.13 | 409,534.94 | 325,969.6 | 126,400.2 |
| 减:营业外支出 | 1,736,379.13 | 1,643,475.79 | 124,624.28 | 75,699.72 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 61,702,060.48 | 197,712,549.99 | 136,903,204.15 | 94,887,413.38 |
| 减:所得税费用 | 15,259,093.58 | 20,729,126.49 | 21,620,293.55 | 14,693,359.67 |
| 六、净利润 | 46,442,966.9 | 176,983,423.5 | 115,282,910.6 | 80,194,053.71 |
| 持续经营净利润 | 46,442,966.9 | 176,983,423.5 | 115,282,910.6 | 80,194,053.71 |
| 归属于母公司股东的净利润 | 46,442,966.9 | 176,983,423.5 | 115,282,910.6 | 80,194,053.71 |
| (一)基本每股收益 | 0.59 | 2.28 | 1.49 | 1.03 |
| (二)稀释每股收益 | 0.59 | 2.28 | 1.49 | 1.03 |
| 九、综合收益总额 | 46,442,966.9 | 176,983,423.5 | 115,282,910.6 | 80,194,053.71 |
| 归属于母公司股东的综合收益总额 | 46,442,966.9 | 176,983,423.5 | 115,282,910.6 | 80,194,053.71 |
| 公告日期 | 2025-04-28 | 2025-03-31 | 2024-10-25 | 2024-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |